Haiyan Yang
3 articles listing Haiyan Yang in Nature Communications, Science Advances, indexed by Paperzzz from Crossref and OSF.
- PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial Nature Communications
- Traversing the Kuroshio: Paleolithic migration across one of the world’s strongest ocean currents Science Advances
- Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trial Nature Communications